| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Patellofemoral Joint | 20 | 2023 | 47 | 10.580 |
Why?
|
| Knee Joint | 61 | 2023 | 574 | 7.760 |
Why?
|
| Cartilage, Articular | 30 | 2023 | 274 | 7.480 |
Why?
|
| Joint Instability | 21 | 2023 | 320 | 7.400 |
Why?
|
| Patella | 16 | 2023 | 55 | 4.500 |
Why?
|
| Patellar Dislocation | 8 | 2023 | 21 | 4.180 |
Why?
|
| Cartilage Diseases | 17 | 2023 | 47 | 4.050 |
Why?
|
| Allografts | 32 | 2023 | 140 | 3.890 |
Why?
|
| Knee Injuries | 16 | 2023 | 125 | 3.860 |
Why?
|
| Anterior Cruciate Ligament Reconstruction | 19 | 2023 | 136 | 3.670 |
Why?
|
| Rotator Cuff Injuries | 12 | 2023 | 236 | 3.320 |
Why?
|
| Shoulder Joint | 17 | 2023 | 523 | 3.100 |
Why?
|
| Humans | 157 | 2023 | 23152 | 3.100 |
Why?
|
| Osteoarthritis, Knee | 19 | 2022 | 296 | 3.040 |
Why?
|
| Bone Transplantation | 17 | 2023 | 154 | 3.010 |
Why?
|
| Arthroscopy | 31 | 2023 | 735 | 3.000 |
Why?
|
| Menisci, Tibial | 22 | 2022 | 94 | 2.950 |
Why?
|
| Ligaments, Articular | 16 | 2023 | 89 | 2.820 |
Why?
|
| Tibial Meniscus Injuries | 8 | 2022 | 47 | 2.640 |
Why?
|
| Platelet-Rich Plasma | 7 | 2023 | 40 | 2.620 |
Why?
|
| Femur | 15 | 2022 | 309 | 2.500 |
Why?
|
| Patellar Ligament | 5 | 2023 | 33 | 2.260 |
Why?
|
| Anterior Cruciate Ligament Injuries | 12 | 2023 | 142 | 2.230 |
Why?
|
| Cadaver | 19 | 2023 | 292 | 2.160 |
Why?
|
| Tendons | 11 | 2023 | 172 | 1.990 |
Why?
|
| Transplantation, Homologous | 25 | 2023 | 177 | 1.960 |
Why?
|
| Retrospective Studies | 44 | 2023 | 3036 | 1.880 |
Why?
|
| Cartilage | 9 | 2022 | 70 | 1.790 |
Why?
|
| Tomography, X-Ray Computed | 13 | 2020 | 600 | 1.740 |
Why?
|
| Tendon Injuries | 6 | 2022 | 159 | 1.650 |
Why?
|
| Adult | 62 | 2023 | 7038 | 1.640 |
Why?
|
| Osteotomy | 13 | 2022 | 124 | 1.620 |
Why?
|
| Rotator Cuff | 9 | 2023 | 225 | 1.600 |
Why?
|
| Intra-Articular Fractures | 4 | 2022 | 12 | 1.580 |
Why?
|
| Bankart Lesions | 2 | 2023 | 13 | 1.530 |
Why?
|
| Tenodesis | 7 | 2023 | 141 | 1.480 |
Why?
|
| Biomechanical Phenomena | 14 | 2023 | 534 | 1.460 |
Why?
|
| Tibia | 15 | 2022 | 192 | 1.430 |
Why?
|
| Patient Reported Outcome Measures | 21 | 2023 | 366 | 1.320 |
Why?
|
| Chondrocytes | 7 | 2022 | 103 | 1.310 |
Why?
|
| Quadriceps Muscle | 2 | 2020 | 27 | 1.300 |
Why?
|
| Magnetic Resonance Imaging | 13 | 2023 | 901 | 1.290 |
Why?
|
| Fractures, Stress | 3 | 2020 | 16 | 1.280 |
Why?
|
| Young Adult | 31 | 2023 | 1713 | 1.260 |
Why?
|
| Adolescent | 28 | 2023 | 1897 | 1.240 |
Why?
|
| Anterior Cruciate Ligament | 7 | 2022 | 135 | 1.210 |
Why?
|
| Return to Sport | 9 | 2020 | 111 | 1.190 |
Why?
|
| Treatment Outcome | 38 | 2023 | 3038 | 1.160 |
Why?
|
| Arthroplasty, Subchondral | 3 | 2018 | 17 | 1.160 |
Why?
|
| Male | 62 | 2023 | 12524 | 1.130 |
Why?
|
| Middle Aged | 48 | 2022 | 7997 | 1.110 |
Why?
|
| Bone Marrow | 6 | 2023 | 58 | 1.100 |
Why?
|
| Female | 59 | 2023 | 13031 | 1.080 |
Why?
|
| Suture Anchors | 4 | 2023 | 66 | 1.060 |
Why?
|
| Imaging, Three-Dimensional | 11 | 2020 | 163 | 1.030 |
Why?
|
| Meniscus | 3 | 2023 | 11 | 1.020 |
Why?
|
| Quality of Life | 8 | 2022 | 548 | 1.000 |
Why?
|
| Computer Simulation | 4 | 2021 | 174 | 0.990 |
Why?
|
| Arthroplasty, Replacement, Knee | 8 | 2023 | 559 | 0.990 |
Why?
|
| Bone-Patellar Tendon-Bone Grafting | 4 | 2023 | 23 | 0.960 |
Why?
|
| Return to Work | 6 | 2020 | 39 | 0.960 |
Why?
|
| Shoulder | 8 | 2022 | 142 | 0.930 |
Why?
|
| Activities of Daily Living | 7 | 2022 | 427 | 0.920 |
Why?
|
| Bone Diseases | 2 | 2022 | 20 | 0.910 |
Why?
|
| Follow-Up Studies | 23 | 2022 | 1457 | 0.870 |
Why?
|
| Suture Techniques | 6 | 2023 | 116 | 0.860 |
Why?
|
| Arthritis | 2 | 2022 | 45 | 0.820 |
Why?
|
| Shoulder Dislocation | 2 | 2022 | 89 | 0.810 |
Why?
|
| Scapula | 3 | 2019 | 77 | 0.800 |
Why?
|
| Musculoskeletal Diseases | 1 | 2023 | 34 | 0.800 |
Why?
|
| Pain | 12 | 2023 | 339 | 0.780 |
Why?
|
| Orthopedic Procedures | 8 | 2020 | 237 | 0.760 |
Why?
|
| Range of Motion, Articular | 11 | 2022 | 600 | 0.750 |
Why?
|
| Surgeons | 2 | 2021 | 78 | 0.740 |
Why?
|
| Second-Look Surgery | 3 | 2020 | 8 | 0.720 |
Why?
|
| Meniscectomy | 3 | 2020 | 13 | 0.710 |
Why?
|
| Fibrin Tissue Adhesive | 2 | 2022 | 4 | 0.660 |
Why?
|
| Hyaline Cartilage | 2 | 2017 | 7 | 0.660 |
Why?
|
| Humeral Head | 3 | 2022 | 28 | 0.640 |
Why?
|
| Reoperation | 15 | 2021 | 764 | 0.630 |
Why?
|
| Tissue Adhesives | 1 | 2019 | 4 | 0.610 |
Why?
|
| Reproducibility of Results | 8 | 2021 | 596 | 0.590 |
Why?
|
| Bone Resorption | 1 | 2019 | 76 | 0.580 |
Why?
|
| Pain, Postoperative | 6 | 2022 | 280 | 0.580 |
Why?
|
| Stifle | 1 | 2018 | 8 | 0.570 |
Why?
|
| Femur Head | 2 | 2015 | 50 | 0.560 |
Why?
|
| X-Ray Microtomography | 1 | 2018 | 72 | 0.550 |
Why?
|
| Minimal Clinically Important Difference | 5 | 2022 | 112 | 0.550 |
Why?
|
| Animals | 11 | 2023 | 3253 | 0.540 |
Why?
|
| Osteoporosis | 1 | 2018 | 71 | 0.540 |
Why?
|
| Femoracetabular Impingement | 3 | 2020 | 223 | 0.530 |
Why?
|
| Transplantation, Autologous | 8 | 2023 | 94 | 0.530 |
Why?
|
| Osteolysis | 1 | 2016 | 113 | 0.480 |
Why?
|
| Postoperative Period | 10 | 2020 | 268 | 0.480 |
Why?
|
| Wound Healing | 4 | 2023 | 117 | 0.450 |
Why?
|
| Analgesics, Opioid | 3 | 2021 | 214 | 0.420 |
Why?
|
| Osteochondritis Dissecans | 3 | 2019 | 16 | 0.420 |
Why?
|
| Patient Satisfaction | 7 | 2021 | 267 | 0.410 |
Why?
|
| Muscle, Skeletal | 4 | 2022 | 331 | 0.400 |
Why?
|
| Gamma Rays | 1 | 2013 | 11 | 0.400 |
Why?
|
| Arm | 3 | 2022 | 69 | 0.400 |
Why?
|
| Sheep | 2 | 2023 | 16 | 0.390 |
Why?
|
| Computers | 2 | 2022 | 15 | 0.370 |
Why?
|
| Risk Factors | 6 | 2021 | 1944 | 0.350 |
Why?
|
| Aged | 15 | 2021 | 7448 | 0.350 |
Why?
|
| Biological Products | 2 | 2023 | 29 | 0.340 |
Why?
|
| Growth Plate | 2 | 2020 | 13 | 0.330 |
Why?
|
| Amniotic Fluid | 2 | 2019 | 4 | 0.310 |
Why?
|
| Sports Medicine | 2 | 2022 | 27 | 0.310 |
Why?
|
| Psychometrics | 2 | 2020 | 177 | 0.310 |
Why?
|
| Radiography | 3 | 2021 | 555 | 0.290 |
Why?
|
| Amnion | 2 | 2018 | 3 | 0.270 |
Why?
|
| Prospective Studies | 9 | 2023 | 1507 | 0.270 |
Why?
|
| Hyaluronic Acid | 4 | 2021 | 33 | 0.260 |
Why?
|
| Athletic Injuries | 4 | 2019 | 135 | 0.260 |
Why?
|
| Joint Diseases | 2 | 2020 | 95 | 0.250 |
Why?
|
| Child | 4 | 2022 | 1136 | 0.250 |
Why?
|
| Collagen | 3 | 2023 | 78 | 0.250 |
Why?
|
| Bone and Bones | 2 | 2018 | 109 | 0.250 |
Why?
|
| Shoulder Injuries | 3 | 2019 | 114 | 0.250 |
Why?
|
| Recurrence | 3 | 2021 | 261 | 0.240 |
Why?
|
| Survivorship | 2 | 2023 | 15 | 0.240 |
Why?
|
| Cohort Studies | 8 | 2023 | 1445 | 0.230 |
Why?
|
| Weight-Bearing | 2 | 2018 | 131 | 0.230 |
Why?
|
| Shoulder Pain | 2 | 2020 | 51 | 0.230 |
Why?
|
| Arthroplasty | 2 | 2023 | 114 | 0.210 |
Why?
|
| Ligaments | 1 | 2023 | 11 | 0.210 |
Why?
|
| Injections, Intra-Articular | 6 | 2021 | 58 | 0.210 |
Why?
|
| Debridement | 3 | 2018 | 74 | 0.210 |
Why?
|
| Bone Screws | 2 | 2023 | 126 | 0.200 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2020 | 28 | 0.200 |
Why?
|
| Time Factors | 5 | 2019 | 1265 | 0.200 |
Why?
|
| Autografts | 2 | 2023 | 19 | 0.190 |
Why?
|
| Clinical Trials as Topic | 3 | 2018 | 191 | 0.190 |
Why?
|
| Ossification, Heterotopic | 1 | 2022 | 33 | 0.190 |
Why?
|
| Posterior Cruciate Ligament Reconstruction | 1 | 2022 | 6 | 0.190 |
Why?
|
| Fractures, Bone | 1 | 2023 | 70 | 0.190 |
Why?
|
| Neurosurgical Procedures | 1 | 2023 | 139 | 0.180 |
Why?
|
| Electrosurgery | 1 | 2021 | 5 | 0.180 |
Why?
|
| Glenoid Cavity | 1 | 2022 | 29 | 0.180 |
Why?
|
| Tendinopathy | 2 | 2015 | 37 | 0.180 |
Why?
|
| Surgical Instruments | 1 | 2021 | 21 | 0.180 |
Why?
|
| Rotation | 1 | 2021 | 115 | 0.170 |
Why?
|
| Network Meta-Analysis | 2 | 2021 | 24 | 0.170 |
Why?
|
| Postoperative Complications | 4 | 2020 | 817 | 0.170 |
Why?
|
| Epiphyses | 1 | 2020 | 8 | 0.170 |
Why?
|
| Perioperative Period | 1 | 2020 | 8 | 0.170 |
Why?
|
| Knee | 1 | 2020 | 38 | 0.160 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 769 | 0.160 |
Why?
|
| Bone Marrow Cells | 1 | 2020 | 50 | 0.160 |
Why?
|
| Viscosupplements | 1 | 2019 | 5 | 0.160 |
Why?
|
| Genu Varum | 1 | 2019 | 2 | 0.160 |
Why?
|
| Cattle | 2 | 2018 | 111 | 0.160 |
Why?
|
| Opioid-Related Disorders | 1 | 2021 | 57 | 0.160 |
Why?
|
| Desiccation | 1 | 2019 | 2 | 0.150 |
Why?
|
| Pain Measurement | 5 | 2020 | 428 | 0.150 |
Why?
|
| Motion Therapy, Continuous Passive | 1 | 2019 | 5 | 0.150 |
Why?
|
| Chorion | 1 | 2018 | 1 | 0.150 |
Why?
|
| Umbilical Cord | 1 | 2018 | 3 | 0.150 |
Why?
|
| Guided Tissue Regeneration | 1 | 2018 | 8 | 0.150 |
Why?
|
| Software | 1 | 2019 | 51 | 0.150 |
Why?
|
| Leukocytes | 2 | 2016 | 31 | 0.150 |
Why?
|
| Humerus | 2 | 2020 | 90 | 0.150 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2019 | 59 | 0.150 |
Why?
|
| Arthralgia | 4 | 2020 | 103 | 0.140 |
Why?
|
| Anesthetics, Local | 2 | 2009 | 70 | 0.140 |
Why?
|
| Tissue Banks | 1 | 2018 | 3 | 0.140 |
Why?
|
| Bone Marrow Transplantation | 1 | 2017 | 14 | 0.140 |
Why?
|
| Quality Improvement | 1 | 2018 | 119 | 0.140 |
Why?
|
| Research Design | 1 | 2018 | 159 | 0.140 |
Why?
|
| Multivariate Analysis | 4 | 2020 | 284 | 0.140 |
Why?
|
| Posterior Cruciate Ligament | 2 | 2019 | 18 | 0.130 |
Why?
|
| Athletes | 1 | 2017 | 60 | 0.130 |
Why?
|
| Rupture | 2 | 2014 | 85 | 0.130 |
Why?
|
| Sodium Chloride | 1 | 2016 | 32 | 0.130 |
Why?
|
| Bone Malalignment | 1 | 2016 | 16 | 0.130 |
Why?
|
| Stem Cell Transplantation | 1 | 2016 | 35 | 0.120 |
Why?
|
| Soft Tissue Injuries | 1 | 2016 | 14 | 0.120 |
Why?
|
| ROC Curve | 3 | 2020 | 123 | 0.120 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 514 | 0.120 |
Why?
|
| Orthopedics | 1 | 2016 | 83 | 0.120 |
Why?
|
| Graft Survival | 4 | 2017 | 82 | 0.120 |
Why?
|
| Time-to-Treatment | 1 | 2015 | 29 | 0.110 |
Why?
|
| Tissue Donors | 2 | 2019 | 58 | 0.110 |
Why?
|
| Sex Characteristics | 1 | 2015 | 85 | 0.110 |
Why?
|
| Ontario | 3 | 2020 | 13 | 0.110 |
Why?
|
| Cryopreservation | 2 | 2018 | 12 | 0.110 |
Why?
|
| Preoperative Period | 3 | 2020 | 67 | 0.110 |
Why?
|
| Hip Injuries | 1 | 2013 | 12 | 0.110 |
Why?
|
| Lacerations | 1 | 2013 | 13 | 0.100 |
Why?
|
| Elbow Joint | 1 | 2015 | 115 | 0.100 |
Why?
|
| Pectoralis Muscles | 1 | 2013 | 16 | 0.100 |
Why?
|
| Stress, Mechanical | 1 | 2013 | 127 | 0.100 |
Why?
|
| Proteoglycans | 3 | 2022 | 118 | 0.100 |
Why?
|
| Recovery of Function | 3 | 2020 | 249 | 0.100 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2012 | 28 | 0.100 |
Why?
|
| Postoperative Care | 2 | 2013 | 112 | 0.100 |
Why?
|
| Tendon Transfer | 1 | 2012 | 15 | 0.100 |
Why?
|
| Popliteal Vein | 1 | 2012 | 2 | 0.090 |
Why?
|
| Popliteal Artery | 1 | 2012 | 3 | 0.090 |
Why?
|
| Vascular Surgical Procedures | 1 | 2012 | 22 | 0.090 |
Why?
|
| Tissue Transplantation | 2 | 2008 | 12 | 0.090 |
Why?
|
| Baseball | 1 | 2013 | 92 | 0.090 |
Why?
|
| Intraoperative Complications | 1 | 2012 | 60 | 0.090 |
Why?
|
| Heart Arrest | 1 | 2012 | 39 | 0.090 |
Why?
|
| Upper Extremity | 2 | 2021 | 51 | 0.090 |
Why?
|
| Acetabulum | 1 | 2012 | 190 | 0.090 |
Why?
|
| Visual Analog Scale | 2 | 2020 | 60 | 0.080 |
Why?
|
| Odds Ratio | 2 | 2020 | 223 | 0.080 |
Why?
|
| Methylprednisolone | 1 | 2009 | 18 | 0.080 |
Why?
|
| Lidocaine | 1 | 2009 | 20 | 0.080 |
Why?
|
| Surveys and Questionnaires | 3 | 2020 | 1021 | 0.080 |
Why?
|
| United States | 3 | 2021 | 1794 | 0.080 |
Why?
|
| Tissue Engineering | 1 | 2008 | 24 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 159 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2019 | 160 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 72 | 0.070 |
Why?
|
| Bupivacaine | 1 | 2008 | 39 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 46 | 0.070 |
Why?
|
| Freezing | 1 | 2008 | 11 | 0.070 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2008 | 64 | 0.070 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2008 | 55 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 82 | 0.070 |
Why?
|
| Tissue Scaffolds | 2 | 2020 | 20 | 0.060 |
Why?
|
| Prostheses and Implants | 1 | 2006 | 128 | 0.060 |
Why?
|
| Incidence | 2 | 2018 | 634 | 0.060 |
Why?
|
| Treatment Failure | 2 | 2018 | 130 | 0.050 |
Why?
|
| Radiostereometric Analysis | 1 | 2023 | 6 | 0.050 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2022 | 22 | 0.050 |
Why?
|
| Documentation | 1 | 2022 | 19 | 0.050 |
Why?
|
| Elbow | 1 | 2021 | 41 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 90 | 0.050 |
Why?
|
| Information Systems | 1 | 2021 | 18 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2021 | 87 | 0.040 |
Why?
|
| Workers' Compensation | 1 | 2021 | 54 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2020 | 58 | 0.040 |
Why?
|
| Machine Learning | 1 | 2021 | 66 | 0.040 |
Why?
|
| Sports | 1 | 2020 | 42 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2020 | 16 | 0.040 |
Why?
|
| Survival Rate | 1 | 2021 | 307 | 0.040 |
Why?
|
| Morphine | 1 | 2020 | 70 | 0.040 |
Why?
|
| Rehabilitation | 1 | 2019 | 11 | 0.040 |
Why?
|
| Logistic Models | 1 | 2020 | 341 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2019 | 89 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2010 | 216 | 0.040 |
Why?
|
| Fracture Fixation, Internal | 1 | 2019 | 57 | 0.040 |
Why?
|
| Ankle | 1 | 2019 | 20 | 0.040 |
Why?
|
| Aggrecans | 1 | 2019 | 48 | 0.040 |
Why?
|
| Ankle Joint | 1 | 2019 | 40 | 0.040 |
Why?
|
| Lysholm Knee Score | 1 | 2018 | 4 | 0.040 |
Why?
|
| Joint Dislocations | 1 | 2019 | 50 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 29 | 0.040 |
Why?
|
| Research Subjects | 1 | 2018 | 9 | 0.040 |
Why?
|
| Demography | 1 | 2018 | 57 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2020 | 563 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2020 | 396 | 0.040 |
Why?
|
| Multipotent Stem Cells | 1 | 2017 | 1 | 0.040 |
Why?
|
| Chondrogenesis | 1 | 2017 | 23 | 0.030 |
Why?
|
| Biocompatible Materials | 2 | 2008 | 71 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 3711 | 0.030 |
Why?
|
| Osteogenesis | 1 | 2017 | 101 | 0.030 |
Why?
|
| Contraindications | 1 | 2016 | 26 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 501 | 0.030 |
Why?
|
| Orthopedic Fixation Devices | 1 | 2016 | 18 | 0.030 |
Why?
|
| Physical Examination | 1 | 2016 | 94 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1040 | 0.030 |
Why?
|
| Arthroplasty, Replacement, Shoulder | 1 | 2017 | 187 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2013 | 10 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2013 | 204 | 0.030 |
Why?
|
| Acute Disease | 1 | 2013 | 164 | 0.020 |
Why?
|
| Models, Biological | 1 | 2013 | 292 | 0.020 |
Why?
|
| Pulmonary Edema | 1 | 2012 | 21 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2013 | 525 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 104 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 230 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2010 | 67 | 0.020 |
Why?
|
| Prosthesis Fitting | 1 | 2009 | 17 | 0.020 |
Why?
|
| Body Height | 1 | 2009 | 31 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2009 | 34 | 0.020 |
Why?
|
| Chondromalacia Patellae | 1 | 2009 | 1 | 0.020 |
Why?
|
| Organ Size | 1 | 2009 | 85 | 0.020 |
Why?
|
| Anesthetics | 1 | 2009 | 19 | 0.020 |
Why?
|
| Body Weight | 1 | 2009 | 128 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2009 | 113 | 0.020 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2008 | 10 | 0.020 |
Why?
|
| Substance P | 1 | 2008 | 10 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2008 | 56 | 0.020 |
Why?
|
| Axons | 1 | 2008 | 24 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2008 | 28 | 0.020 |
Why?
|
| Random Allocation | 1 | 2008 | 106 | 0.020 |
Why?
|
| Rabbits | 1 | 2008 | 165 | 0.020 |
Why?
|
| Sex Factors | 1 | 2009 | 389 | 0.020 |
Why?
|
| Hip Joint | 1 | 2012 | 387 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2008 | 13 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2008 | 18 | 0.020 |
Why?
|
| Compressive Strength | 1 | 2008 | 12 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2009 | 380 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2008 | 48 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 335 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 449 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2008 | 470 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2008 | 387 | 0.020 |
Why?
|
| Polyurethanes | 1 | 2006 | 5 | 0.020 |
Why?
|
| Polycarboxylate Cement | 1 | 2006 | 5 | 0.020 |
Why?
|
| Connective Tissue | 1 | 2006 | 20 | 0.020 |
Why?
|
| Models, Animal | 1 | 2006 | 99 | 0.020 |
Why?
|
| Prognosis | 1 | 2008 | 722 | 0.020 |
Why?
|
| Palliative Care | 1 | 2007 | 106 | 0.020 |
Why?
|
| Materials Testing | 1 | 2006 | 104 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2006 | 311 | 0.020 |
Why?
|
| Algorithms | 1 | 2007 | 317 | 0.010 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2008 | 290 | 0.010 |
Why?
|
| Rats | 1 | 2006 | 609 | 0.010 |
Why?
|